- Report
- October 2024
- 194 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- February 2024
- 86 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
Ethyl bromoacetate is a pharmaceutical intermediate used in the production of active pharmaceutical ingredients (APIs). It is a colorless liquid with a pungent odor and is highly reactive. It is used in the synthesis of a variety of APIs, including antibiotics, antifungals, and antivirals. It is also used in the production of other pharmaceutical intermediates, such as esters, amides, and amines.
Ethyl bromoacetate is produced by the reaction of ethyl alcohol and bromoacetic acid. It is widely available in the market and is used in a variety of applications. It is also used in the production of agrochemicals, dyes, and fragrances.
Some of the major companies in the ethyl bromoacetate market include Merck KGaA, Sigma-Aldrich, TCI Chemicals, Alfa Aesar, and Acros Organics. Show Less Read more